Theratechnologies Inc. Company Profile | StatInvestor

Health Care & Life Sciences » Biotechnology | Theratechnologies Inc.

Theratechnologies Inc.

Theratechnologies Inc.
Stock Exchange	Other OTC
EPS	$0.05
Market Cap	$399.46 M
Shares Outstanding	76.66 M
Public Float	-

Theratechnologies Inc.
Stock Exchange	Frankfurt Stock Exchange
EPS	-
Market Cap	-
Shares Outstanding	76.66 M
Public Float	-

Theratechnologies Inc.
Stock Exchange	Toronto Stock Exchange Prices
EPS	CAD0.06
Market Cap	CAD518.16 M
Shares Outstanding	65.93 M
Public Float	64.76 M

Profile

Address	2015 Peel Street Montréal Québec H3A 1T8 Canada
Employees	-
Website	http://www.theratech.com
Updated	07/08/2019
Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). It offers its product under the brand name of EGRIFTA, which approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montreal, Canada.

Financials

Luc Tanguay

President, Chief Executive Officer & Director

Dawn Svoronos

Chairman